Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression
Lund University.
Lund University.
Lund University.
Lund University.
2004 (English)In: BMC Cancer, ISSN 1471-2407, E-ISSN 1471-2407, Vol. 4, no 80Article in journal (Refereed) Published
Abstract [en]

Background: Transcription factors are frequently involved in the process of cellular transformation, and many malignancies are characterized by a distinct genetic event affecting a specific transcription factor. This probably reflects a tissue specific ability of transcription factors to contribute to the generation of cancer but very little is known about the precise mechanisms that governs these restricted effects. Methods: To investigate this selectivity in target gene activation we compared the overall gene expression patterns by micro-array analysis and expression of target genes for the transcription factor EBF in lymphoma and neuroblastoma cells by RT-PCR. The presence of transcription factors in the different model cell lines was further investigated by EMSA analysis. Results: In pre-B cells mb-1 and CD19 are regulate by EBF-1 in collaboration with Pax-5 and E-proteins. We here show that neuroblastoma cells express these three, for B cell development crucial transcription factors, but nevertheless fail to express detectable levels of their known target genes. Expression of mb-1 could, however, be induced in neuroblastoma cells after disruption of the chromatin structure by treatment with 5-azacytidine and Trichostatin A. Conclusion: These data suggest that transcription factors are able to selectively activate target genes in different tissues and that chromatin structure plays a key role in the regulation of this activity.

Place, publisher, year, edition, pages
BioMed Central , 2004. Vol. 4, no 80
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:liu:diva-74455DOI: 10.1186/1471-2407-4-80ISI: 000226525400001OAI: oai:DiVA.org:liu-74455DiVA: diva2:484783
Available from: 2012-01-27 Created: 2012-01-27 Last updated: 2017-12-08

Open Access in DiVA

fulltext(1183 kB)367 downloads
File information
File name FULLTEXT01.pdfFile size 1183 kBChecksum SHA-512
dff604fdf7f0766b6b7f4fb92100001a9e2a6d6adce366e48c34bd7fca230084f8b6981bdbe7c923180bc5d627ffee693cca96776dea3e8fd5a1076b18ace947
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Sigvardsson, Mikael
In the same journal
BMC Cancer
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar
Total: 367 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 73 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf